Integer Holdings

ITGR

Market cap $2.46B

For 3Q25, the Macquarie Small Cap Value Fund Institutional class shares lagged the stronger return of its benchmark, the Russell 2000 Value Index. Stock selection and an underweight allocation detracted in the healthcare sector. Stock selection in technology detracted as the Fund's positions in the semiconductors and semiconductor equipment industries underperformed.

PLANO, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, announced today that members of its executive leadership team will participate at the following investor conferences in December: Piper Sandler 37 th Annual Healthcare Conference at 8:00 a.m. ET on Tuesday, Dec. 2 Citi's 2025 Global Healthcare Conference at 9:45 a.m.

PLANO, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that its Board of Directors has authorized a share repurchase program of up to $200 million of the Company's outstanding common stock. “This share repurchase program reflects the confidence of the Board and management in our strategy, financial position, and ability to generate strong free cash flows,” said Payman Khales, Integer's president and CEO.

Integer CEO Khales Payman bought 3,127 shares of the company's stock on Oct. 30, 2025. Mr. Payman purchased his company's stock on the day shares hit a 52-week low of $62.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Integer Holdings faces a sharp valuation reset after revising 2026 guidance to flat sales and earnings, shocking investors. Despite strong organic growth and margin recovery in 2023-2024-2025, Integer´s 2026 outlook signals a sudden halt in momentum. Leverage remains elevated and CEO transition adds uncertainty, compounding concerns after aggressive customer demand changes.

Integer Holdings posts strong Q3 results with earnings and revenue beat, but shares plunge on a softer 2026 growth outlook.

Integer Holdings Corporation (NYSE:ITGR) reported better-than-expected earnings for the third quarter on Thursday.

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due to the company's updated financial projections for the remainder of 2025 and a disappointing preliminary forecast for 2026, both adversely affected by the slower-than-expected uptake of new products.

~ Planned Leadership Transition Completed ~ PLANO, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today shared that, as part of a planned transition originally announced in April 2025, Payman Khales has assumed the role of President and Chief Executive Officer. He also joins the company's Board of Directors.